Standout Papers

Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy 2022 2026 2023 2024116
  1. Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy (2022)
    Qingfang Li, Zhihui Li et al. Molecular Biomedicine
  2. Targeted therapy for head and neck cancer: signaling pathways and clinical studies (2023)
    Qingfang Li, Yan Tie et al. Signal Transduction and Targeted Therapy

Immediate Impact

52 standout
Sub-graph 1 of 23

Citing Papers

Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
2025 Standout
Macrophage plasticity: signaling pathways, tissue repair, and regeneration
2024 Standout
2 intermediate papers

Works of Qingfang Li being referenced

Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin
2021
Safety and efficacy of durvalumab (MEDI4736) in various solid tumors
2018

Author Peers

Author Last Decade Papers Cites
Qingfang Li 313 412 96 230 37 963
Lian Xu 440 464 75 309 39 1.1k
Roger Mouawad 300 511 121 175 57 946
Tetsuji Sawada 385 489 112 198 38 913
Yun Hee Kang 329 523 79 208 44 1000
D Glaves 378 346 152 203 41 984
Jianjun Yu 214 450 122 196 52 926
Barbara Vergani 261 327 70 168 46 930
Philipp Manegold 438 398 111 145 23 901
Marion T. Weigel 324 470 108 265 27 1.0k
Vildan Yasasever 452 428 61 191 52 939

All Works

Loading papers...

Rankless by CCL
2026